Suppliers / Deccan Nutraceuticals

Deccan Nutraceuticals

India 84 employees Updated 9 July 2026

Deccan Nutraceuticals is an API manufacturer based in India. It holds one active US drug master file and one valid CEP. Its most recent recorded inspection, by US FDA, closed on 20 April 2023 as NAI. Customs aggregates show $2.0M of exports covering 84 molecules to 19 destinations in 2025.

1
active US DMFs
1
valid CEPs
2
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
4 of 4 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 20 April 2023 NAI US FDA
  • 10 August 2018 VAI US FDA
  • 26 February 2016 VAI US FDA
  • 30 January 2014 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Pune, India Not on file
Pune, India 3007607026

What they file, and where

Molecule Regulators Docs
Digoxin EDQM, SFDA (Saudi Arabia), US FDA 3

Also appears on these molecule pages

Digoxin API

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $442K 8
2025 Not reported $2.0M 19
2024 Not reported $1.2M 17
2023 Not reported $1.1M 11

Export figures are customs aggregates. We do not publish the identity of any buyer.

Questions about Deccan Nutraceuticals

Does Deccan Nutraceuticals hold a US DMF or a CEP?
Deccan Nutraceuticals holds 1 active US drug master file and 1 valid CEP. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Deccan Nutraceuticals FDA-registered?
One site operated by Deccan Nutraceuticals carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Deccan Nutraceuticals's last inspection go?
The most recent inspection on record closed on 20 April 2023 as NAI (No Action Indicated: nothing objectionable was found). 4 inspections are on file.
Where does Deccan Nutraceuticals manufacture?
2 registered sites are on record, in India (Pune among others). Every site is listed on this page with the register it came from.
What does Deccan Nutraceuticals make?
1 molecule is on record against Deccan Nutraceuticals, including Digoxin. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Deccan Nutraceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was NAI, on 20 April 2023.

Comparable suppliers

Alchem International shares 1 molecule Roche Diagnostics shares 1 molecule Ambition Pharma also in India Andhra Organics also in India Anjan Drug also in India

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
Customs aggregates
Export values, molecule and destination counts